Literature DB >> 1490896

Suppression of the 2f1-f2 otoacoustic emission in humans.

F P Harris1, R Probst, L Xu.   

Abstract

Suppression of the 2f1-f2 distortion-product otoacoustic emission (DPOAE), stimulated with primaries, f1 and f2, in the frequency regions of 1, 2, and 4 kHz was measured in one ear of 14 human subjects with normal hearing. Suppression rate functions were generated with a suppressor at either 1, 2, or 4 kHz increasing in level from 30 to 76 dB SPL for the corresponding f1 and f2 combinations. Stimulus levels for DPOAEs were L1 = 70 dB SPL and L2 adjusted to produce the highest amplitude DPOAE for each ear (range, 0 to 6 dB below L1). Results indicated that DPOAEs were reduced 3 dB in amplitude for a mean suppressor level of 61 dB SPL. Maximum amplitude reduction occurred at a mean suppressor level of 69 dB SPL. These levels varied little for the three stimulus frequency regions. Mean slopes of the rate functions decreased as stimulus frequency region increased. Suppression tuning curves (STCs) were generated in the same three frequency regions and with L1 at either 70 or 55 dB SPL and L2 adjusted individually for each ear. The tips of the STCs were at frequencies associated with f1 and f2. The tip regions of the STCs for the 4-kHz stimulus condition were more complex in that they contained more multiple minima than did those for the 1- and 2-kHz regions. Results confirm that optimal suppression of the 2f1-f2 DPOAE occurs for frequencies in the vicinity of f1 and f2 rather than at 2f1-f2.

Entities:  

Mesh:

Year:  1992        PMID: 1490896     DOI: 10.1016/0378-5955(92)90175-m

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


  11 in total

1.  Influence of calibration method on distortion-product otoacoustic emission measurements: I. test performance.

Authors:  Sienna R Burke; Abigail R Rogers; Stephen T Neely; Judy G Kopun; Hongyang Tan; Michael P Gorga
Journal:  Ear Hear       Date:  2010-08       Impact factor: 3.570

2.  Influence of primary-level and primary-frequency ratios on human distortion product otoacoustic emissions.

Authors:  Tiffany A Johnson; Stephen T Neely; Cassie A Garner; Michael P Gorga
Journal:  J Acoust Soc Am       Date:  2006-01       Impact factor: 1.840

3.  Stimulus-frequency otoacoustic emission suppression tuning in humans: comparison to behavioral tuning.

Authors:  Karolina K Charaziak; Pamela Souza; Jonathan H Siegel
Journal:  J Assoc Res Otolaryngol       Date:  2013-09-07

4.  The role of suppression in psychophysical tone-on-tone masking.

Authors:  Joyce Rodríguez; Stephen T Neely; Harisadhan Patra; Judy Kopun; Walt Jesteadt; Hongyang Tan; Michael P Gorga
Journal:  J Acoust Soc Am       Date:  2010-01       Impact factor: 1.840

5.  Temporal aspects of suppression in distortion-product otoacoustic emissions.

Authors:  Joyce Rodriguez; Stephen T Neely
Journal:  J Acoust Soc Am       Date:  2011-05       Impact factor: 1.840

6.  Estimating cochlear frequency selectivity with stimulus-frequency otoacoustic emissions in chinchillas.

Authors:  Karolina K Charaziak; Jonathan H Siegel
Journal:  J Assoc Res Otolaryngol       Date:  2014-09-18

7.  Acoustic distortion products from the cochlea of the blind African mole rat, Cryptomys spec.

Authors:  M Kössl; G Frank; H Burda; M Müller
Journal:  J Comp Physiol A       Date:  1996       Impact factor: 1.836

8.  Exploration of stimulus-frequency otoacoustic emission suppression tuning in hearing-impaired listeners.

Authors:  Karolina K Charaziak; Pamela E Souza; Jonathan H Siegel
Journal:  Int J Audiol       Date:  2014-10-07       Impact factor: 2.117

9.  Distortion-product otoacoustic emissions in the common marmoset (Callithrix jacchus): parameter optimization.

Authors:  M D Valero; E G Pasanen; D McFadden; R Ratnam
Journal:  Hear Res       Date:  2008-05-23       Impact factor: 3.208

10.  Distortion Product Otoacoustic Emissions: A Tool for Hearing Assessment and Scientific Study.

Authors:  Caroline Abdala; Leslie Visser-Dumont
Journal:  Volta Rev       Date:  2001
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.